maria-mohlen
Restylane is not only about beauty. I can see that our products bring in so many other values in people’s lives as well.
Maria Molén Training & Account Manager Nordic countries

Products

img-spot

Career

img-spot

Press

img-spot

A GLOBAL LEADER IN AESTHETIC AND CORRECTIVE TREATMENTS

Q-Med, a Galderma division, develops, manufactures and markets solutions for aesthetic and corrective treatments.

The division offers a complete worldwide portfolio in the aesthetic field including the brands Restylane, Emervel and Macrolane. Deflux, Solesta and Durolane are other products improving patients’ health in the corrective field.

Since 2011, Q-Med is wholly owned by Galderma, a pharmaceutical company with nearly 4 000 employees specialized in dermatology and present in more than 70 countries. The site in Uppsala, Sweden, is  Galderma’s Global Aesthetic Center of Excellence with world-class research and development and manufacturing.

For more information about Galderma, please visit www.galderma.com

 

 Visit Restylane
 Visit Emervel
 Visit Macrolane

News

2011-12-21 Restylane on Facebook Did you know that we have a global Restylane page on Facebook? Read more
2011-12-20 Restylane for Lips Worldwide launch of two new Restylane products for naturally plump and soft lips. Read more
2011-12-19 Our mission: new products to the market Didier Leclercq has been Managing Director at Q-Med, a Galderma division, since November 1, 2011. Read more
2011-12-01 Compulsory acquisition After a compulsory acquisition procedure, Galderma Holding AB now controls 100 percent of the shares in Q-Med AB. Read more
Archive